These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 16580726)

  • 1. Paradoxical discrepancy between the serum level and the placental intensity of PP5/TFPI-2 in preeclampsia and/or intrauterine growth restriction: possible interaction and correlation with glypican-3 hold the key.
    Ogawa M; Yanoma S; Nagashima Y; Okamoto N; Ishikawa H; Haruki A; Miyagi E; Takahashi T; Hirahara F; Miyagi Y
    Placenta; 2007; 28(2-3):224-32. PubMed ID: 16580726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subcellular localization of PP5/TFPI-2 in human placenta: a possible role of PP5/TFPI-2 as an anti-coagulant on the surface of syncytiotrophoblasts.
    Udagawa K; Yasumitsu H; Esaki M; Sawada H; Nagashima Y; Aoki I; Jin M; Miyagi E; Nakazawa T; Hirahara F; Miyazaki K; Miyagi Y
    Placenta; 2002; 23(2-3):145-53. PubMed ID: 11945080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased placental expression of Placental Protein 5 (PP5) / Tissue Factor Pathway Inhibitor-2 (TFPI-2) in women with preeclampsia and HELLP syndrome: Relevance to impaired trophoblast invasion?
    Karaszi K; Szabo S; Juhasz K; Kiraly P; Kocsis-Deak B; Hargitai B; Krenacs T; Hupuczi P; Erez O; Papp Z; Kovalszky I; Than NG
    Placenta; 2019 Jan; 76():30-39. PubMed ID: 30803712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes of plasma and placental tissue factor pathway inhibitor-2 in women with preeclampsia and normal pregnancy.
    Xiong Y; Zhou Q; Jiang F; Zhou S; Lou Y; Guo Q; Liang W; Kong D; Ma D; Li X
    Thromb Res; 2010 Jun; 125(6):e317-22. PubMed ID: 20347477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction.
    Chafetz I; Kuhnreich I; Sammar M; Tal Y; Gibor Y; Meiri H; Cuckle H; Wolf M
    Am J Obstet Gynecol; 2007 Jul; 197(1):35.e1-7. PubMed ID: 17618748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Placental localization and expression of the cell death factors BNip3 and Nix in preeclampsia, intrauterine growth retardation and HELLP syndrome.
    Stepan H; Leo C; Purz S; Höckel M; Horn LC
    Eur J Obstet Gynecol Reprod Biol; 2005 Oct; 122(2):172-6. PubMed ID: 16219518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal serum levels of placental protein 5 in complications of late pregnancy.
    Salem HT; Westergaard JG; Hindersson P; Lee JN; Grudzinskas JG; Chard T
    Obstet Gynecol; 1982 Apr; 59(4):467-71. PubMed ID: 7078900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between plasma and placental tissue factor, and tissue factor pathway inhibitors in severe pre-eclampsia patients.
    Teng Y; Jiang R; Lin Q; Ding C; Ye Z
    Thromb Res; 2010 Jul; 126(1):e41-5. PubMed ID: 20226500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Placental expression of syndecan 1 is diminished in preeclampsia.
    Jokimaa VI; Kujari HP; Ekholm EM; Inki PL; Anttila L
    Am J Obstet Gynecol; 2000 Dec; 183(6):1495-8. PubMed ID: 11120517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the role of placental trisomy in preeclampsia and intrauterine growth restriction.
    Robinson WP; Peñaherrera MS; Jiang R; Avila L; Sloan J; McFadden DE; Langlois S; von Dadelszen P
    Prenat Diagn; 2010 Jan; 30(1):1-8. PubMed ID: 19918961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of maternal and umbilical serum TNFalpha levels in preeclamptic pregnancies in the intrauterine normal and growth-restricted fetus.
    Laskowska M; Leszczyńska-Gorzelak B; Laskowska K; Oleszczuk J
    J Matern Fetal Neonatal Med; 2006 Jun; 19(6):347-51. PubMed ID: 16801311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemostatic variables as independent predictors for fetal growth retardation in preeclampsia.
    Schjetlein R; Abdelnoor M; Haugen G; Husby H; Sandset PM; Wisløff F
    Acta Obstet Gynecol Scand; 1999 Mar; 78(3):191-7. PubMed ID: 10078579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression patterns of two serine protease HtrA1 forms in human placentas complicated by preeclampsia with and without intrauterine growth restriction.
    Lorenzi T; Marzioni D; Giannubilo S; Quaranta A; Crescimanno C; De Luca A; Baldi A; Todros T; Tranquilli AL; Castellucci M
    Placenta; 2009 Jan; 30(1):35-40. PubMed ID: 19056122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release of inositol phosphoglycan P-type by the human placenta following insulin stimulus: a multiple comparison between preeclampsia, intrauterine growth restriction, and gestational hypertension.
    Scioscia M; Paine MA; Gumaa K; Rodeck CH; Rademacher TW
    J Matern Fetal Neonatal Med; 2008 Aug; 21(8):581-5. PubMed ID: 18609357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated maternal levels of the long pentraxin 3 (PTX3) in preeclampsia and intrauterine growth restriction.
    Cetin I; Cozzi V; Pasqualini F; Nebuloni M; Garlanda C; Vago L; Pardi G; Mantovani A
    Am J Obstet Gynecol; 2006 May; 194(5):1347-53. PubMed ID: 16647920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor, its receptors, and the tie receptors in the placental bed of women with preeclampsia, diabetes, and intrauterine growth retardation.
    Vuorela P; Halmesmäki E
    Am J Perinatol; 2006 May; 23(4):255-63. PubMed ID: 16625496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of serine proteinase inhibitor PP5/TFPI-2/MSPI decreases the invasive potential of human choriocarcinoma cells in vitro and in vivo.
    Jin M; Udagawa K; Miyagi E; Nakazawa T; Hirahara F; Yasumitsu H; Miyazaki K; Nagashima Y; Aoki I; Miyagi Y
    Gynecol Oncol; 2001 Nov; 83(2):325-33. PubMed ID: 11606093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short telomeres may play a role in placental dysfunction in preeclampsia and intrauterine growth restriction.
    Biron-Shental T; Sukenik-Halevy R; Sharon Y; Goldberg-Bittman L; Kidron D; Fejgin MD; Amiel A
    Am J Obstet Gynecol; 2010 Apr; 202(4):381.e1-7. PubMed ID: 20350645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of N-myc downstream-regulated gene 1 (NDRG1) in placentas from pregnancies complicated by intrauterine growth restriction or preeclampsia.
    Choi SJ; Oh SY; Kim JH; Sadovsky Y; Roh CR
    Am J Obstet Gynecol; 2007 Jan; 196(1):45.e1-7. PubMed ID: 17240229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of galectin-1, -3 (gal-1, gal-3) and the Thomsen-Friedenreich (TF) antigen in normal, IUGR, preeclamptic and HELLP placentas.
    Jeschke U; Mayr D; Schiessl B; Mylonas I; Schulze S; Kuhn C; Friese K; Walzel H
    Placenta; 2007; 28(11-12):1165-73. PubMed ID: 17664004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.